News

Discern Health Summarizes CMS’ Latest Guidance on the MIPS Value Pathways Framework

February 2020

Discern Health joined and summarized the February 12th Centers for Medicare & Medicaid Services (CMS) MIPS Value Pathways (MVPs) Public Webinar, which provided an overview of the MIPS Value Pathways participation framework outlined in the 2020 Physician Fee Schedule / Quality Payment Program (PFS/QPP) Final Rule. The purpose of the webinar was to describe the…

Read more

Tokia Day Joins Discern Health as Finance and Operations Manager

February 2020

Tokia Day recently joined Discern Health as the finance and operations manager. In this role, she provides oversight to ensure that Discern is financially prudent and in compliance with standards set by Generally Accepted Accounting Principles (GAAP) and other regulating bodies. Tokia’s work helps Discern quantitively assess its current performance to produce measurable outcomes and…

Read more

Discern Health Contributes to the Serious Illness Quality Alignment Hub Strategic Plan

February 2020

The Serious Illness Quality Alignment Hub (“the Hub”), a coordinated effort to develop a national strategic plan that will incentivize and/or require delivery of high-quality care for people living with a serious illness, has released the final version of the Hub Strategic Plan. The Hub is a three-year effort of the Center to Advance Palliative…

Read more

Discern Health Co-Authors JITC Article on Quality Measures for Cancer Immunotherapy

February 2020

In conjunction with the Society for Immunotherapy of Cancer (SITC), Discern Health Partner Tom Valuck and Director David Blaisdell co-authored the new Journal of ImmunoTherapy of Cancer (JITC) article, “Defining Current Gaps in Quality Measures for Cancer Immunotherapy: Consensus Report from the Society for Immunotherapy of Cancer (SITC) 2019 Quality Summit.” The article identifies four…

Read more

Discern Health Announces Staff Promotions

January 2020

Discern Health is excited to announce the promotion of three Discern Project Analysts—Tess Donckels, Palak Patel, and Rachael Peroutky—to Project Managers. They have each demonstrated the ability to manage complex projects and develop creative approaches and solutions that help our clients succeed in the value-based care environment. As a Project Manager, Tess Donckels contributes to…

Read more

Patient Perspectives on Value-Based Care from the NCCN Patient Advocacy Summit

January 2020

One of the biggest barriers to patient-centered care is the gap between patient views of value-based care and physician and health system views. In December, Discern Health attended the National Comprehensive Cancer Network (NCCN) Patient Advocacy Summit: Delivering Value for Patients Across the Oncology Ecosystem in Washington, DC. The summit highlighted the patient perspective on…

Read more

Discern Health Welcomes Norris Turner as a Senior Advisor

January 2020

Discern Health welcomes Norris Turner, PharmD, PhD, as a Senior Advisor. Norris leads Turner Healthcare Quality Consulting, LLC, in advancing projects with biopharmaceutical clients to optimize the value they deliver to patients, payers, and providers. In his affiliation with Discern, Norris will use his nearly 20 years of experience in the pharmaceutical industry and deep knowledge…

Read more

Quality Outlook Blog: We Need Better Quality Measures for Oncology Care First

January 2020

In the latest installment of Discern Health’s Quality Outlook blog series in the Journal of Clinical Pathways, Partner Tom Valuck and Directors Manasi Tirodkar and David Blaisdell discuss the new oncology value-based care model, Oncology Care First (OCF), and emphasize the critical opportunity to advance clinical quality measurement for oncology care by addressing important gaps…

Read more

Discern Health Welcomes David Wierz as a Senior Advisor

December 2019

Discern Health welcomes David Wierz as a Senior Advisor. David leads projects for life sciences clients to apply analytics to implement strategies that define value and promote access. In his affiliation with Discern, David will use his payment and care delivery policy knowledge to help life sciences companies develop product value strategies that enhance clinical,…

Read more

Quality Outlook Blog: Aligning Quality Measurement with Oncology Innovation

December 2019

In the latest installment of Discern Health’s Quality Outlook blog series in the Journal of Clinical Pathways (JCP), Partner Tom Valuck and Directors David Blaisdell and Theresa Schmidt highlight the challenge of keeping quality measures up to date as new evidence and guidelines are rapidly updated and breakthrough treatments transform clinical practice. “Catch Me If…

Read more

Discern expands Health Economics and Outcomes Research (HEOR) Capabilities For Life Sciences clients

Health economics and outcomes research (HEOR) has long been important for health care market access outside the U.S., but it is increasingly being utilized in the U.S. as part of the movement from vol...
Learn More

About

About

Capabilities

Capabilities

Contact

Contact Us

Insights

Insights

Guy D’Andrea Speaks About Innovative Payment Models

Click here to view the VIDEO